Skip to main content

Air Products & Chemicals, Inc.

For the period ended Sep 30, 2025. Filed Nov 20, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Nov 20, 2025

APD$304.84-1.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Capital Stock

  1. CAPITAL STOCK

Common Stock

Authorized common stock consists of 300 million shares with a par value of $1 per share. As of 30 September 2025,249 million shares were issued, with 223 million issued and outstanding.

On 15 September 2011, the Board of Directors authorized the repurchase of up to $1.0 billion of our outstanding common stock. This program does not have a stated expiration date. If we repurchase shares pursuant to this authorization, we may do so under Rules 10b5-1 and 10b-18 under the Securities Exchange Act through repurchase agreements established with one or more brokers. We have not purchased any of our outstanding shares under this program since fiscal year 2013. As of 30 September 2025, $485.3 in share repurchase authorization remained available.

A summary of the changes in common shares issued and outstanding in fiscal year 2025 is presented below:

Fiscal Year Ended 30 September202520242023
Number of common shares, beginning of year222,372,418222,199,845221,838,696
Issuance of treasury shares for stock option and award plans215,838172,573361,149
Number of common shares, end of year222,588,256222,372,418222,199,845

Preferred Stock

Authorized preferred stock consisted of 25 million shares with a par value of $1 per share. There wereno preferred shares issued or outstanding as of 30 September 2025 and 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.